Andera Partners

Andera Partners, established in 2001 and previously known as Edmond de Rothschild Investment Partners, is a private equity firm based in Paris, France. The firm specializes in investing in unlisted companies across France and internationally, managing over €2 billion in assets. Its investment focus includes life sciences, growth capital, and sponsorless mezzanine debt. Andera Partners targets investments typically ranging from €10 million to €20 million, with a commitment to fostering long-term performance through autonomous, experienced teams that anticipate economic trends. The firm operates within a framework that emphasizes tailored solutions and a close relationship with its clients, reflecting the legacy and values of the Edmond de Rothschild Group, which has a long-standing reputation in European finance.

Nicolas Aftimos

Investor

Guy Auger

Partner

Pierre Barruet

Financial Controller

Sabrina Bazire

Invesment Director

Vincent Bazzocchi

Investor

Stéphane Bergez

Partner

Jean-Baptiste Bessières

Director and Oenophile

Jerome Bevierre

Chief Financial Officer

Antoine Le Bourgeois

Partner

Léopold Brichard

Investor

Xavier Buisson

Director

Andrei Buzdugan

CFO

Mayeul Caron

Partner

Pierre Cavalier

Analyst​

Elyes Chouaieb

Investor

Nicolas Debonneuil

Senior Associate Andera Expansion and Curious

Aurelie Denieuil

Senior Investment Manager and Committed

Aïchatou Diop

COO

Gontran Duchesne

Director Andera Croissance and Globe-Trotter

Thomas Duteil

Investment Director

Arnaud Faure

Partner

Alexandre Foulon

Investment Director

Olivier Le Gall

Partner

Francesco Gonzaga

Investor

Antoine Guerillon

Associate

Marianne Harlé

Director Andera Croissance and Horsewoman

Sofia Ioannidou

Partner

Julia Joannot

Associate

Pierre-Luc Wilain de Leymarie

Associate

Olivier Litzka Ph.D

Partner

Christine Martinovic

Director

François-Xavier Mauron

Partner

Thibault Menel

Associate Andera Croissance and Eclectic Sportsman

Arthur Milliard

Investor

Gilles Nobecourt

Partner

Pierre-Michel Passy

Founding Partner and President

Mathieu Piéronne

Investor

Prune Des Roches

Partner and Audacious Leader

Etienne Rossignol

Investor

Antoine Soucaze

Investment Manager and Cheerful

Quentin Tarasconi

Investment Manager and Creative

Tanguy Tauzinat

Investment Director

Laurent Tourtois

Partner

Verane Wierucki

Investment Manager and the Quiet Strength

Yuexin Yu

Investor

Past deals in France

Resonance Imaging Group

Venture Round in 2022
Resonance Imaging Group provides all patients with access to medical imaging, for increasingly precise diagnoses.

HR Path

Private Equity Round in 2022
HR Path is a global consultancy specializing in human capital management, with a focus on HR Systems Integration, HR Outsourcing, and HR Business Consulting. Founded in 2001 by François Boulet and Cyril Courtin, the company is headquartered in Paris and operates in 13 countries across North America, Europe, and the Middle East, employing over 500 consultants. HR Path offers a range of software solutions, including proprietary tools like BiHRdy for business intelligence, Pandore for HR and payroll management, and Geef for talent management. Additionally, it serves as an authorized reseller for various software solutions in the French market, including those from SAP and Oracle HCM. With a diverse client portfolio that includes large corporations, small and medium-sized enterprises, and public sector organizations, HR Path generates approximately €60 million in annual revenue, supporting clients in their digital transformation and enhancing the efficiency of HR operations through technology.

Kyotherm

Venture Round in 2022
Kyotherm SAS is an investment company based in Paris, France, that focuses on financing renewable heating and energy efficiency projects. Established in 2011, it provides project equity to support the development of energy infrastructure and acquires stakes in various renewable energy production initiatives, including geothermal and biomass heating plants, as well as district heating networks. Kyotherm collaborates with a range of stakeholders, including energy service providers, engineering firms, developers, heat consumers, and equipment manufacturers, to facilitate third-party financing for these projects.

Lhyfe

Venture Round in 2022
Lhyfe is a company based in Nantes, France, that specializes in the design, development, and operation of industrial sites for the production of green hydrogen sourced from renewable energy. Established in 2017, Lhyfe focuses on supplying 100% green hydrogen to support mobility and industrial applications. The company's commitment to sustainable energy solutions positions it as a key player in the transition towards greener energy sources.

Klubb

Venture Round in 2021
Manufacturer of vehicle-mounted access platforms. The company engages in the manufacturing of vehicle-mounted elevators and platforms for various types of commercial vehicles and trucks, enabling users to seamlessly carry out their tasks.

MC2-Technologies

Acquisition in 2021
MC2-Technologies develops innovative equipment for the protection of sites or sensitive infrastructures.

Sogetrel

Acquisition in 2021
Sogetrel is a major player in the telecoms market. Integrator of networks and communication systems for digital irrigation of territories, the Group has established itself as the preferred partner of major operators, public and private contractors, and local authorities, particularly in the deployment of Very High Speed ​​networks.

Sirsa

Venture Round in 2021
SIRSA develops Reporting 21, a Software as a Service platform for the collection and analysis of financial and extra-financial data. It serves businesses and financial institutions. The company was incorporated in 2014 and is based in Paris, France.

Dynacure

Series C in 2020
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.

Mastergrid

Private Equity Round in 2019
MasterGrid is a manufacturer and supplier of high voltage electrical equipment based in Grenoble, France. Formerly known as Merlin Gerin, the company was incorporated in 2019 and focuses on providing electric products, solutions, and services tailored to the needs of both the commercial and industrial sectors.

Opportunity

Private Equity Round in 2019
Opportunity SAS is a company based in Paris, France, founded in 2005, specializing in debt recovery and risk management solutions. It provides a comprehensive range of services including payment reminders, card protection, survey design, personal video communications, video signatures, record signatures, push notifications, and mail services. Additionally, Opportunity offers multi-channel delivery capabilities, data integration, and portal services. The company also focuses on marketing automation and provides a software as a service (SaaS) platform for customer interaction management. Opportunity is recognized for its commitment to enhancing digital customer relationship management projects, serving clients across various sectors both in France and internationally.

Olaqin

Acquisition in 2019
Olaqin SAS is a company based in Suresnes, France, specializing in the distribution of electronic healthcare transaction management systems, software, and integrated solutions. Founded in 2012, Olaqin offers a range of products including electronic transaction and payment processing devices, such as self-service, counter, fixed, and mobile solutions, as well as mixed health and banking solutions. The company serves pharmacies, healthcare professionals, and medical institutions, providing essential tools for managing health transactions efficiently. Olaqin was previously known as Ingenico Healthcare France before rebranding in November 2019. Its focus is on facilitating transactions within the healthcare sector.

Inotrem

Series B in 2019
Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Ellisphere

Acquisition in 2019
Ellisphere is a reference for decision-making information, supporting and securing the decision-making of company executives and decision-makers in France and internationally via the BIGnet network, by providing them with economic and financial information on their trading partners.

99 Advisory

Acquisition in 2019
99 Advisory is a banking and insurance sectors are facing radical changes in their environments.

Travelsoft

Private Equity Round in 2019
Travelsoft SAS, founded in 2016 and based in Paris, France, develops software solutions specifically tailored for the travel industry. The company offers Orchestra, a Software-as-a-Service platform designed to assist professionals in producing, administrating, distributing, and managing leisure services within the travel sector. Through its innovative software offerings, Travelsoft aims to enhance operational efficiency and streamline processes for various stakeholders in the travel market.

Spherea

Venture Round in 2019
A company that provides solutions for critical electronic and optronic system testing globally.

HR Path

Private Equity Round in 2019
HR Path is a global consultancy specializing in human capital management, with a focus on HR Systems Integration, HR Outsourcing, and HR Business Consulting. Founded in 2001 by François Boulet and Cyril Courtin, the company is headquartered in Paris and operates in 13 countries across North America, Europe, and the Middle East, employing over 500 consultants. HR Path offers a range of software solutions, including proprietary tools like BiHRdy for business intelligence, Pandore for HR and payroll management, and Geef for talent management. Additionally, it serves as an authorized reseller for various software solutions in the French market, including those from SAP and Oracle HCM. With a diverse client portfolio that includes large corporations, small and medium-sized enterprises, and public sector organizations, HR Path generates approximately €60 million in annual revenue, supporting clients in their digital transformation and enhancing the efficiency of HR operations through technology.

Tournus Equipement

Private Equity Round in 2019
Tournus Equipement manufactures stainless steel environments for professional kitchens and supermarket fish counters. It offers mobile, modular, and customizable professional kitchens; regeneration ovens, pans and grids, warmers, sterilizing cabinets, gutters and floor drains, trolleys, containers, insect-killers, fish counters, wash-basins, dishwashing equipment, kitchen units, catering units, sinks, units, dustbins, shelving products, temperature reheating products, warming cabinets, coolers, and tables; self-service lines for meal distribution; custom equipment; and bins and tables for loading and unloading dishwashers.

Verbraeken Infra

Acquisition in 2019
Verbraeken Infra builds and renovates utility infrastructure networks for gas, water, electricity and telecom companies. Vebraeken-Infra generates sales of € 140 million annually, with 1.000 employees across Belgium, France and Germany. Waterland supports Infra Group in its continued expansion in Europe and beyond. This growth strategy resulted in expansion of Verbraeken-Infra’s footprint both organically as well as through acquisitions in France, Germany and the Benelux and has strengthened Verbraeken-Infra’s leading market position in Belgium.

HighLife

Series B in 2019
HighLife SAS is a medtech company that specializes in developing a novel transcatheter mitral valve replacement system aimed at treating patients with mitral regurgitation. Founded in 2010 and headquartered in Paris, France, with an additional office in Irvine, California, the company focuses on providing a minimally invasive prosthetic mitral valve that can be implanted on a beating heart. This approach preserves the native valve structure and respects the surrounding anatomy, ensuring reduced trauma during surgical procedures. HighLife's technology is designed for ease and safety of use, as well as optimal treatment outcomes, allowing for delivery through a transseptal passage via the femoral vein. The system is currently undergoing clinical evaluation to assess its effectiveness in addressing severe heart conditions.

Lease Protect

Acquisition in 2019
Lease Protect has specialized in the fight against shrinkage by offering a range of products and services for video surveillance, security gates and customer counting. Under the leadership of its leaders, the offer focused specifically on the small and medium-sized business market thanks to local proximity, responsiveness enabled by the integration of the latest technologies connected to their equipment, and innovative financing solutions. Leasing products and services.

BioClinic

Private Equity Round in 2018
BioClinic operates medical analysis laboratories in the Ile-de-France region. The company was founded in 1995 and is based in Paris, France.

Solware Group

Private Equity Round in 2018
Solware Group operates as a software publisher for actors in the medico-social sector. Solware Group offer innovative, robust and scalable software that responds appropriately to the needs of users and the challenges of their business dailies.

Groupe JORYF

Private Equity Round in 2018
Groupe JORYF is specialist group of housing construction in Ile-de-France.

Skill and You

Acquisition in 2018
Skill and You is the leading provider of vocational e-learning in France with its commitments to innovation and professionalism. Employment is a major issue today, and Skill and You is positioned to deliver to learners real results and qualifications (BAC PRO, BEP, BP, BTS, CAP) via our effective pedagogy and adaptable education technology. Leveraging our group’s experiences and deep knowledge, we’ve built a strong track record of successful schools across sectors, empowering learners to change their lives.

Dynacure

Series A in 2018
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.

orbility

Private Equity Round in 2018
orbility is a provider of off-street parking applications and programs.The company's parking assistance tools offers complete operational and management control of the car parking system being used. Its client base include airports, shopping centers, airports, municipalities, public and private operators.

ENYO Pharma

Series B in 2018
ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, focused on drug discovery and development for acute and chronic viral infections. Founded in 2014 by a group of scientists from the Infectiology Research Center, the company has established a unique platform to identify intracellular therapeutic targets and molecules, particularly for human pathogens. ENYO Pharma is developing treatments for significant viral infections, with ongoing programs targeting chronic hepatitis B and severe influenza. Its lead compound, EYP001, is designed to modulate FXR and reduce viral replication, while EYP002 is currently undergoing preclinical studies. The company aims to advance its pipeline into Phase II clinical trials and collaborates closely with research institutions to leverage innovative therapeutic strategies. ENYO Pharma is committed to addressing unmet medical needs in infectious and metabolic diseases, positioning itself as a leader in antiviral therapies.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Biogroup-LCD

Debt Financing in 2018
BIOGROUP-LCD, a major French player in local medical biology, supports more than 20,000 patients every day and offers more than 2000 routine and specialized daily examinations, based on performance and technological innovation. Partner at every moment between the patient and the medical profession, your laboratory participates in the screening, diagnosis, monitoring and prognosis of the most common pathologies to the most demanding, throughout your course of care. BIOGROUP-LCD develops for this purpose all its human and technological resources. The team of qualified, qualified medical biologists follows continuous and regular training.

erytech

Private Equity Round in 2017
ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

walor

Private Equity Round in 2017
The WALOR Group (12 production sites in 5 countries, 1600 employees) is the European leader in the mechanical parts market, specializing in the design and production of forgings and machined parts (engines, gearbox, steering ...) and counts among its customers the largest manufacturers, system operators and automotive suppliers.

Globe Groupe

Private Equity Round in 2017
GLOBE Groupe sa provides advertising services. The company offers strategic planning and communication strategy services. It also provides advertising, non-media planning, talent castings, recruitment, training, and payroll services. The company also offers storage, kitting, dispatch, cold-chain logistics, stand installation, after-sales checks, parking reservations, and permits. It caters to consumer goods, media, retailers, media, and recruitment industries. GLOBE Groupe sa is based in Paris, France.

TimeOne Group

Acquisition in 2017
Created in 2016, TimeOne is a marketing services group formed from two online marketing specialists, Public-Idées and Place des Leads. The group’s core offering is to provide content and data solutions. With a well-established reputation in prescriptive marketing and a common technological base (DMP), TimeOne is founded on innovation and realized through research and development. TimeOne offers a comprehensive range of online marketing solutions: Programmatic, Native, Performance, digital Marketplace, Publishing and Mobile. The company has a presence in France, in the United-Kingdom, in Spain, Italy, South Africa, Asia and South America.

La Vie Saine

Private Equity Round in 2017
SA La Vie Saine engages in the retail of organic products. Its products include dairy products, food supplements, fruits and vegetables, grocery, bakery, hygiene products, meat, and wine. The company was founded in 1952 and is headquartered in Dijon, France.

Loyalty Company

Venture Round in 2017
Groupe conseil en marketing client et communication, nativement inspiré par la data et les nouvelles technologies.

Allodiagnostic

Acquisition in 2017
Allodiagnostic SAS offers real estate diagnoses, such as termites, electrical, and energy performance on behalf of private individuals during the rental or sale of a property. The company was incorporated in 2001 and is based in Paris, France. As of July 21, 2017, Allodiagnostic SAS operates as a subsidiary of Edmond de Rothschild (France).

Intech

Private Equity Round in 2017
IN’TECH MEDICAL is an industry leader in the development and manufacturing of surgical instruments for the Orthopaedic industry. IN’TECH delivers expertise in all aspects of surgical instrument including development and manufacturing. Their services encompass contract manufacturing and contract designing. IN’TECH have a strong track record of turning original ideas into new solutions for their customers.

SARAWAK

Acquisition in 2017
Sarawak Group is a company specialized in setting up Sales-, Merchandising- and Brand Activation services. We seek to accelerate the performance and results of sales of products and services of our customers.

Studia group

Private Equity Round in 2017
STUDIA S.A.S. offers consultancy services specializing in enterprise content management (ECM) and document engineering. The company offers services like advice for implementation, strategic consulting, advice for digital data processing, support services, industrial engineering services, risk control, and documentary engineering. Additionally, it also offers digital transition and business support services. It serves customers in sectors, including energy, industry, tertiary/public, and defense. STUDIA S.A.S. was founded in 2009 and is based in Meyreuil, France.

Groupe 3S

Private Equity Round in 2017
Founded in 2001, the Groupe 3S , thanks to the synergy of the expertise of its subsidiaries and its financial soundness is now one of the world leaders in services. Several of his companies are focused on assistance to airline ground handling and other services from the airport managers.

Klaxcar

Acquisition in 2017
Klaxcar France S.A., founded in 1993 and headquartered in Dourdan, France, specializes in manufacturing automotive spare parts. The company focuses on the aftermarket sector, offering products that meet Original Part quality standards while maintaining competitive pricing. Klaxcar aims to provide reliable solutions for automotive needs, catering to a diverse range of customers in the automotive industry.

Minafin

Private Equity Round in 2017
Minafin is a global fine chemicals developer and manufacturer. Minafin develops and manufactures active ingredients, organic intermediates, and specialty fine chemicals for the life science industries and technical applications.

Bacacier group

Private Equity Round in 2017
Bacacier is a manufacture steel and the associated CO2 emissions have been halved.

NetCo

Venture Round in 2016
Groupe NetCo specializes in the design, manufacture, assembly, maintenance, and installation of conveyor systems, including both belt and roller types. The company offers a diverse range of conveyor belts made from rubber and various polymers, along with specialized accessories such as wipers, rollers, and drive pulleys. NetCo also provides services like on-site installation, training for conveyor belt operation, and custom transformations of conveyor belts. Serving a wide array of industries, including waste management, logistics, agrifood, pharmaceuticals, and energy sectors, the company has established itself as a leader in the domestic market within a decade of operation. Founded in 1902 and based in Bordeaux, France, Groupe NetCo was previously known as PERRIEZ and rebranded in 1999.

The Reefer Group

Private Equity Round in 2016
The Reefer Group SL through its subsidiaries designs and manufactures refrigerated semi trailers. manufactures refrigerated vehicles for temperature controlled transportation applications in France and internationally. It offers new and used semi-trailers and trucks; other products, such as tractor-trailers, removable bodies, and utility vehicles; and used vehicles for road haulage of meat, dairy products, fruits and vegetables, flowers, and pharmaceutical products. The company also offers spare parts, servicing and repairs, and rebuilding services; and services, such as liveries, rentals, after-sales training, vehicle upgrades and special equipment, and sells second-hand vehicles. It offers products through its sales network. The company was incorporated in 2015 and is based in Alzira, Spain.

MS Vacances

Venture Round in 2016
MS Vacances SAS offers boarding, hospitality and lodging services. The company was incorporated in 1992 and is based in Nantes, France.

Atland

Venture Round in 2016
Founded in 2006, Foncière Atland is a real estate investment trust (REIT), active in Ile-de-France and other regions. The firm invests, asset manages and executes turnkey developments and also manages collective real estate funds through its subsidiary, Voisin. The company's shareholders include Crédit Foncier and Tikéhau Capital, as well as Edmond de Rothschild Investment Partners at Groupe Atland.

Ipside

Venture Round in 2016
The IPSIDE firm assists and advises clients in the process of obtaining, operation and defense of their patents of invention, both in France and abroad. Other ways to protect technical inventions are also included to allow the implementation of the overall strategy of the most appropriate Intellectual Property for the company. We also assist our clients in the development of their technical and legal strategies for operation of their inventions.

MedDay

Series B in 2016
MedDay is an innovative biopharmaceutical company specializing in the development of therapies for neurodegenerative diseases by targeting key neurometabolic pathways. Established in 2016, the company aims to create disease-modifying treatments that provide solutions for patients, caregivers, and the healthcare community, addressing significant unmet medical needs. MedDay's focus is on investigating brain metabolism to develop neuroprotective and neurorepair therapies, with promising clinical trial outcomes guiding their research efforts. By exploring disrupted metabolic pathways in the central nervous system, MedDay seeks to enhance future treatment options for individuals suffering from nervous system disorders.

La Toulousaine

Private Equity Round in 2016
La Toulousaine is a French company based in Escalquens, established in 1975, that specializes in the design and manufacture of various building materials. The company produces an extensive range of products, including gates, fences, garage doors, sectional doors, shutters, and security railings. Additionally, La Toulousaine offers metal curtains and mechanical shutters tailored for commercial establishments. Its product line also includes automatic systems and accessories to enhance functionality and security. With a focus on both residential and industrial applications, La Toulousaine serves a diverse clientele in the building materials sector.

Sogetrel

Private Equity Round in 2016
Sogetrel is a major player in the telecoms market. Integrator of networks and communication systems for digital irrigation of territories, the Group has established itself as the preferred partner of major operators, public and private contractors, and local authorities, particularly in the deployment of Very High Speed ​​networks.

Sfam

Private Equity Round in 2016
Fondée en 1999, SFAM est une société de courtage en assurances, filiale de SFK Group. Dotée d’un capital de 2 000 000 d’euros, SFAM crée, commercialise et gère des solutions et des services d'assurance affinitaires. A ses débuts, SFAM se spécialise dans la conception de produits d'assurance destinés exclusivement aux domaines du multimédia et de la téléphonie. Puis elle élargit petit à petit son offre au domaine de l'optique, de l'électroménager, de l'e-commerce, de la protection conducteur et plus récemment à l’ensemble des produits connectés du foyer. Toujours attentive à l'évolution des besoins de ses clients et du marché, la société intègre au fil des années de nouveaux domaines d'activité et accroît par la même occasion sa notoriété. Soucieuse d'innover et de développer les services attendus par ses clients, SFAM propose dès 2009, dans le cadre de ses solutions d'assurances mobile et multimédia, la prise en compte de la perte de l’appareil assuré et de la négligence dans la réalisation des sinistres. En 2013, elle innove de nouveau en intégrant aux contrats d’assurance la reprise des anciens téléphones portables. La flexibilité des garanties et l'éventail des formules proposées par SFAM sont très certainement au cœur de sa réussite. En recherche constante d’équilibre entre ses offres commerciales, leur rapport qualité-prix et la qualité des garanties proposées, SFAM se positionne rapidement comme un acteur majeur de son secteur d'activité. Elle compte actuellement plus de 500 000 clients et de 1500 partenaires installés sur l’ensemble du territoire. Dans sa relation avec ses partenaires commerciaux, SFAM met un point d’honneur à leur délivrer la meilleure formation et à les accompagner dans l’amélioration de leur service clientèle. Elle met ainsi ses 110 collaborateurs à leur disposition afin de leur offrir leur expertise et leur savoir-faire dans les différents domaines d'activité. Egalement très proche de ses adhérents, la société SFAM accorde également une place essentielle à son service clientèle. Elle met en effet à leur disposition un système de traitement des demandes et de gestion des réponses permettant de satisfaire aux mieux ses clients. Par le biais d'un service client multicanal, la SFAM offre une écoute et une disponibilité très large à l'ensemble de ses interlocuteurs. SFAM ne cesse de poursuivre son ascension dans le monde des assurances ; le secret de son succès étant sans nul doute la combinaison de son esprit novateur et de sa proximité avec ses clients.

GamaMabs Pharma

Series B in 2015
GamaMabs Pharma SA engages in the development of a new therapeutic antibody for the treatment of ovarian cancer. The company was founded in 2013 and is based in Toulouse, France.

REALEASE Capital

Private Equity Round in 2015
REALEASE Capital offers leasing and financing solutions to the manufacturers of material of videoconference. The company was formerly known as Comiris Capital. The company was founded in 1986 and is based in Puteaux, France.

Groupe ERGET

Venture Round in 2015
Groupe ERGET SA, founded in 1986 and based in Neuilly-sur-Seine, France, operates as a surveyor and loss adjuster specializing in after-claims expertise for insurance companies. The company provides services across various sectors, including construction, aviation, energy, industry, safety, fire protection, product liability, financial lines, personal injury, cyber, and food industry. With a workforce of 120 professionals, including 85 multidisciplinary surveyors, Groupe ERGET has expanded its international presence since 2006, conducting over 5,500 missions in 115 countries, including operations in Asia, South America, and the West Indies. Additionally, a joint venture in more than 30 African countries enhances its global reach. The company generates a turnover of 20 million euros, with 35% of its revenue derived from international markets. Its clientele includes insurers, mutual insurance companies, brokers, industrialists, and legal professionals, underscoring its significant role in the francophone market and its ongoing growth in emerging countries.

Rougnon

Private Equity Round in 2015
Rougnon Group brings together 21 companies specializing in the building trades in Île de France: air conditioning, heating, electricity, plumbing, roofing, waterproofing, security, layout.

Altavia

Venture Round in 2015
Altavia is an independent international group specialising in commercial communication for the retail sector in the world, we are acutely aware of our social, economic and environmental responsibilities and those of our clients.

ACE Group

Venture Round in 2015
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company focuses on facilitating access to mortgage financing for individuals and businesses, providing tailored solutions to meet the specific needs of their clients. By leveraging its expertise in the real estate market, ACE Group aims to simplify the mortgage process, helping clients navigate the complexities of securing funding for property purchases. With a commitment to delivering reliable and efficient services, ACE Group positions itself as a key player in the competitive landscape of mortgage brokerage in France.

Scalian

Acquisition in 2015
Scalian SAS is a consulting firm that specializes in project support and digital transformation services across various industries, including aerospace, defense, security, automotive, railway, and energy. The company offers a wide range of services, including systems and software engineering, data collection and governance, agile change management, and business intelligence analytics. Scalian also provides consulting in engineering and product development, focusing on improving corporate performance and optimizing supply chain quality. Additionally, the firm delivers innovative solutions such as UAV/UGV technology for surveillance, environmental simulation products, and high-performance software diagnostic tools. Founded in 1989 and based in Labege, France, Scalian has expanded its presence with offices in several countries, including Germany, the United Kingdom, and the United States, reflecting its commitment to supporting clients worldwide in their digital transformation efforts.

ACE Group

Private Equity Round in 2015
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company focuses on facilitating access to mortgage financing for individuals and businesses, providing tailored solutions to meet the specific needs of their clients. By leveraging its expertise in the real estate market, ACE Group aims to simplify the mortgage process, helping clients navigate the complexities of securing funding for property purchases. With a commitment to delivering reliable and efficient services, ACE Group positions itself as a key player in the competitive landscape of mortgage brokerage in France.

Emeraude International

Private Equity Round in 2014
Emeraude International SA specializes in the distribution of polymers and chemicals, offering a diverse range of products. The company provides polyolefins and thermoplastic materials, including blown film extrusion polymers used in agricultural films, food packaging, and flexible packaging, as well as blow molding polymers for beverage, cosmetic, and dairy containers. Its product portfolio also includes pipe extrusion polymers for various applications, polypropylene extrusion polymers for industrial fibers, and injection polymers for household items and mechanical parts. In addition to polymers, Emeraude International supplies chemicals and additives for multiple sectors, including food and beverages, paints, agriculture, and personal care. The company also offers supply chain solutions and financial support services to enhance operations for its suppliers and customers. Founded in 1986 and headquartered in Paris, France, Emeraude International serves clients primarily in Africa, the Indian subcontinent, Europe, and Southeast Asia.

Finsecur

Venture Round in 2014
Finsecur S.A. is a French company based in Paris that specializes in the design, manufacture, and maintenance of fire detection and safety systems. Founded in 1989, the company produces a range of products including fire detectors, control panels, extinguishing systems, and technical alarms to monitor installation anomalies. Its offerings cater to various environments such as clean rooms, computer rooms, cold storage facilities, telecommunications, airports, and military industries. Finsecur has been recognized for its innovation and growth, receiving the BPI label Excellence, which connects it with a network of leading high-tech companies in France.

A2IA

Private Equity Round in 2014
A2iA S.A. is a software development company based in Paris, France, with an additional office in New York. Established in 1991, A2iA specializes in creating advanced handwritten and machine-printed text recognition tools, information extraction solutions, and intelligent document classification systems. Its product lineup includes a2ia Mobility for various document workflows, a2ia mNote for converting handwritten notes into digital format on mobile devices, and a2ia DocumentReader for extracting data from diverse document types. The company also offers a2ia TextReader for full text transcription, a2ia CheckReader for automated data capture and fraud mitigation in payment documents, and a2ia FieldReader for processing forms. A2iA serves a wide range of industries, including banking, telecommunications, healthcare, and government, and operates through a network of resellers and distributors globally. As of 2018, A2iA functions as a subsidiary of Mitek Systems, Inc.

Europ Net

Acquisition in 2014
Europ Net II SAS provides cleaning and routine maintenance services for buildings in France. It offers cleanliness of premises, reception and events, factotum and maintenance, green spaces and floral decoration, mail management, management and recovery of waste, multi-service coordination, and security services. The company was founded in 1981 and is based in Nanterre, France. Europ Net II SAS is a former subsidiary of GROUPE SAMSIC.

Maesa

Venture Round in 2014
Maesa SA, based in Levallois Perret, France, specializes in designing and manufacturing custom perfumes, cosmetics, and promotional products for a global market that includes Europe, Asia, and North America. Established in 1997, the company offers a comprehensive suite of services, including brand identity development, industrial and package design, and graphic design. Maesa creates turnkey beauty products and home fragrance offerings tailored for retailers and brands, alongside providing packaging components and promotional items specifically for the beauty industry. The company also acts as a beauty brand incubator, producing exclusive brands and private labels while offering outsourcing services that leverage its design, merchandising, and production capabilities.

Thomson Video Networks

Private Equity Round in 2014
Thomson Video Networks SAS provides video delivery solutions primarily to broadcasters worldwide. The company provides satellite direct to home, digital TV terrestrial, IPTV and Web TV, cable broadcast, contribution and distribution, and mobile TV solutions. It offers video compression systems, including HD encoders, SD encoders, multiscreen video systems, contribution codec platforms, mosaic generators, mobile TV encoders, and statistical multiplexing solutions; processing and multiplexing systems comprising MPEG multiplexers, video processors, DVB-T2 gateways, and network adapters; network management systems; and MPEG stream servers. The company also offers video decoding systems, which include HD/SD decoders, SD decoders, and multi service descramblers; data casting systems, including DVB EPG servers, ATSC PSIP generators, interactive TV broadcasting servers, IP encapsulators, mobile TV electronic service guide generators, and mobile TV encapsulators; and monitoring and switching systems comprising redundancy switchers, digital TV monitors and analyzers, and media file monitors and analyzers. In addition, Thomson Video Networks SAS provides IRDs/descramblers for digital turnaround, monitoring, and contribution applications in terrestrial, DTH, cable, and IPTV/OTT systems. Further, it offers integration, consultancy, support, education and training, and technical support services. The company was incorporated in 2010 and is based in Cesson-Sevigne, France. Thomson Video Networks SAS is a former subsidiary of Grass Valley USA, LLC. Thomson Video Networks SAS operates as a subsidiary of Harmonic Inc.

Poxel

Series B in 2014
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

Groupe ADF

Private Equity Round in 2014
Groupe ADF, a leading provider of industrial engineering and maintenance services, employs 3,900 people in 14 countries, across 4 continents. Specialising in three business lines – engineering & expertise, the supply of production and testing equipment, and production & maintenance services – Groupe ADF serves the Aeronautics, Space & Defense – Industry – Energies – Oil & Gas sectors. In 2016, Groupe ADF acquired Latécoère Services, which was subsquently renamed LATESYS in early 2018. After a record-breaking year, Groupe ADF is expecting to record sales of €411m in 2017.

Passman

Private Equity Round in 2014
Passman SA is a provider of Internet access services, catering primarily to the health and tourism sectors, among others. Established in 1995 and headquartered in Villeurbanne, France, the company specializes in delivering broadband wireless Internet access to its clients. Through its services, Passman aims to enhance connectivity and support the operational needs of various industries.

Inotrem

Series A in 2014
Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Cetal

Acquisition in 2014
CETAL S.A.S. designs and manufactures custom-made heating elements and tubular heating elements for heating equipment and processes worldwide. It offers industrial electric heaters and custom heating elements, cast in heaters, air heaters, high flux heating elements/bolt heaters/forced fluid immersion heaters, circulation heaters and control panels, screw plug immersion heaters, immersion heaters/air duct heaters, and hazardous area heaters.

DufyElec

Acquisition in 2013
DufyElec provides electrical maintenance and rehabilitation.

Genticel

Series D in 2013
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus infections and virus-induced diseases. Genticel aims to become a leader in immunotherapy in multiple indications, starting with HPV and HPV induced diseases such as cervical cancer.

ITESA

Private Equity Round in 2013
ITESA is an independent French distributor specializing in electronic safety equipment, primarily catering to professional clients. Established in 1978 and based in Marseille, the company offers a comprehensive range of products, including alarm panels, perimeter and volumetric detectors, barriers, sound and light signals, and alarm transmission systems. Additionally, ITESA provides video surveillance equipment, intercom systems, automation solutions for portals, and various fire safety products. The company emphasizes innovation and high-value services, enabling its partners to differentiate themselves in the competitive security market. ITESA distributes its products through agencies in France and Switzerland, focusing on meeting the specific needs of its professional clientele.

Poxel

Series B in 2012
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

ProwebCE

Venture Round in 2012
ProwebCE is a privately held company that provides a communication and management platform interfaced to an e-commerce portal.

Alouette

Private Equity Round in 2012
Alouette is a privately held musical, Category B regional radio station.

DEFI Group

Private Equity Round in 2012
DEFI Group specializes in outdoor advertising services, utilizing signs, banners, wallscapes, and LED screens to enhance brand awareness and impact. Founded in 1977 and headquartered in Mitry-Mory, France, the company operates both domestically and internationally, with additional offices across Europe, Asia, and the Middle East. DEFI Group offers a comprehensive range of services, including site prospecting and negotiation, lease management, permit acquisition, technical development, manufacturing, electricity management, and ongoing maintenance of advertising displays. As a leader in spectacular outdoor communication, DEFI Group is distinguished as a unique global entity in its field.

Medcdtll

Venture Round in 2012
Medcdtll provides publication services for medical industry.

Euro Techno Com

Acquisition in 2012
Euro Techno Com S.A.S. distributes equipment used in the deployment and maintenance of the local telecom loop.

In2Bones SAS

Seed Round in 2011
In2Bones SAS is a company based in Ecully, France, focused on designing, manufacturing, and distributing medical devices specifically for extremity surgery, which includes procedures involving the hands and feet. Established in 2011, In2Bones offers a range of products such as single-use instrumentation, osteo-synthesis screws, snap-off screws, staples, implant pips, suture anchors, and inter-positional buttons. The company aims to meet the needs of healthcare professionals by providing innovative and efficient solutions that enhance the quality and performance of surgical procedures. Its products are distributed through a network of distributors both in France and internationally, ensuring accessibility for patients and medical staff alike. In2Bones is dedicated to simplifying surgical processes and improving the management of operating room equipment while prioritizing patient and staff safety.

OCEAN SAS

Venture Round in 2011
OCEAN SAS provides vehicle tracking solutions in France. It engages in the management of a fleet of vehicles and monitoring and piloting the on-the-road activities of its customers; OCEAN vehicle tracking system that allows its customers to obtain the information on a vehicle or its driver; and customizing management solutions, including connection to a personal digital assistant, in-car printer, WAP access, neutralizing of the vehicle, driver identification key, data transfer, and tailor made applications. The company was founded in 2003 and is based in Clichy, France. As of April 16, 2015, OCEAN SAS operates as a subsidiary of Orange Business Services.

Novamex SA

Private Equity Round in 2011
Novamex S.A. produces natural and eco-friendly cleaning, washing, and personal hygiene products to individuals and companies in France. It offers washing powders and liquids, cleaning liquids, shampoos, moisturizers, and hair conditioning products.

SuperSonic Imagine

Series C in 2010
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

Garden Price

Venture Round in 2010
Garden Price is a Les Nouvelles Jardineries, a Maurepas, France-based chain of low-cost garden stores.

Implanet

Series D in 2010
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

Poxel

Series A in 2010
Poxel S.A. is a biopharmaceutical company based in Lyon, France, focused on developing innovative treatments for metabolic diseases, primarily type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009 as a spin-off from Merck Serono, Poxel is advancing its lead product, Imeglimin, through Phase III clinical trials; this oral anti-diabetic candidate targets organ functions affected by diabetes, such as the pancreas, liver, and muscles. The company is also developing PXL770, currently in Phase IIa trials, which activates the adenosine monophosphate-activated protein kinase (AMPK) to manage energy metabolism, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I trials for NASH. Additionally, Poxel has a licensing agreement with Enyo Pharma for the development of PXL007, an FXR agonist in Phase I studies for hepatitis B and NASH. The company’s pipeline reflects its commitment to addressing critical targets in cellular energy regulation, which are vital for treating metabolic disorders.

Implanet

Series C in 2010
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

Genticel

Series C in 2010
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus infections and virus-induced diseases. Genticel aims to become a leader in immunotherapy in multiple indications, starting with HPV and HPV induced diseases such as cervical cancer.

Smile

Venture Round in 2010
Smile offers integration of open source solutions and is based in Levallois-Perret, France.

Implanet

Series B in 2009
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

SuperSonic Imagine

Series B in 2008
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

AJ Tech

Series A in 2008
AJTECH develops and manufactures generators geothermal and aerothermal, which can both heat a home in winter than in summer cooling. Using natural energy (air, water, earth), heat pumps can achieve savings and reduce emissions of certain pollutants including CO2 with a guarantee of comfort throughout the year.

EOS Imaging

Venture Round in 2007
EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries. Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D image of the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany.

Fastbooking

Venture Round in 2007
FastBooking offers leading-edge products and solutions to the hospitality industry to increase profits by maximizing direct bookings and brand visibility in the digital distribution environment. FastBooking is a pioneer in e-marketing and internet-based technologies for independent hotels and hotel groups. FastBooking increases the hotel’s net revenue by maximizing highly profitable direct website bookings and by rationalizing inventory and pricing across all online sales channels. 2012 Fastbooking generated a gross bookings value of over €500m via 8,000 hotels.

Exclusive Group

Venture Round in 2007
Exclusive Group (www.exclusive-group.com) is the value-added services and technologies (VAST) group. As a distributor they help accelerate the global growth of innovative technologies. Their people are committed to the aggressive growth targets set by their vendors, there is a culture of ambition, entrepreneurship and a clear focus on sustainable growth. With more than 60 offices on five continents and presence in 100 countries, Exclusive Group brings together all the elements needed for sustainable growth. New markets and possibilities "Disruptive Distribution" is the core of the proposition. This through the Cybersecurity brand, Exclusive Networks, and the data center division, Bigtec. This can be complemented by comprehensive worldwide services available in the area of ​​implementation and support (ITEC), but also with financial services partners in leasing by Exclusive Capital.

Implanet

Series A in 2007
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.